Tedd Elich

Tedd leads the scientific development of the Life Edit Therapeutics gene-editing platform. He has more than 20 years of biotech experience focused on gene expression and pharmaceutical discovery and was previously Chief Scientific Officer at LifeEDIT Inc. when the company was a subsidiary of AgBiome.